Detected ·
Marea Therapeutics
$225M—
Marea Therapeutics combined with Lisata Therapeutics (Nasdaq: LSTA) in an all-stock transaction, alongside a $225M private placement, to advance its clinical-stage assets for severe hypertriglyceridemia and acromegaly.
- Website
- www.mareatx.com
- Amount
- $225 000 000 USD
- Stage
- —
- Event
- Funding round
- Detected
- 2026-09-18 08:12:47 UTC
- Signal ID
- 9f80660a-ea2a-4962-84fd-1de98257d4d0
As the API returns it
{
"id": "9f80660a-ea2a-4962-84fd-1de98257d4d0",
"created_at": "2026-09-18T08:12:47.948902Z",
"company_name": "Marea Therapeutics",
"company_website_url": "www.mareatx.com",
"company_linkedin_url": "https://www.linkedin.com/company/marea-therapeutics",
"event_type": "funding",
"funding_amount": 225000000,
"funding_currency": "USD",
"funding_stage": null,
"message": "*Marea Therapeutics combined with Lisata Therapeutics (Nasdaq: LSTA) in an all-stock transaction, alongside a $225M private placement, to advance its clinical-stage assets for severe hypertriglyceridemia and acromegaly.*"
}